Are peptides legal in Australia? (2026)

Information as of 2026. This is an educational summary, not legal advice. Consult a qualified lawyer for your situation.

Australia is one of the strictest jurisdictions in the world for peptides. There is no broad "research chemical" gray market the way there is in some other countries: nearly every peptide of interest is a prescription-only medicine, and the Therapeutic Goods Administration (TGA) — Australia's medicines regulator — actively enforces the rules at the border and against suppliers. The short version: a handful of peptides are approved and legal with a valid prescription, and almost everything else is tightly controlled, with importing and supplying unapproved peptides carrying real legal risk.

Approved prescription peptides (legal with a script)

A small number of peptides are registered on the Australian Register of Therapeutic Goods (ARTG) and are entirely legal when prescribed by a doctor and dispensed through a pharmacy. The most prominent are the GLP-1 receptor agonists used for type 2 diabetes and weight management — semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro). These are scheduled as Schedule 4 (Prescription Only Medicines): legal to obtain and use, but only via a valid prescription from an AHPRA-registered practitioner and dispensed by a licensed pharmacy. For these products, legality is straightforward — the approved product, a real prescription, a regulated pharmacy.

Most peptides are Schedule 4 — prescription only

Under the national Poisons Standard (the SUSMP), the great majority of peptides used in clinical and "biohacking" contexts fall under Schedule 4 (Prescription Only Medicine) or are otherwise tightly controlled. That means they cannot lawfully be obtained, possessed for supply, or used without a prescription from a registered medical practitioner. Some peptides have no approved product at all, so even a willing doctor must use a special access pathway (see below) rather than simply writing an ordinary script. The default assumption in Australia should be that a given peptide is prescription-only, not freely available.

"Research only" is not a legal loophole

Vendors frequently label peptides such as BPC-157, TB-500, CJC-1295, ipamorelin and others as "for research use only" or "not for human consumption." In Australia, that label does not create a legal pathway to import, supply, or use these substances in humans. The TGA has been explicit that products supplied this way are still unapproved therapeutic goods when intended for human use, and the "research" framing does not exempt anyone from the Therapeutic Goods Act 1989. The TGA has issued direct warnings about the risks of importing unapproved peptide products, including products in unmarked vials and powders that cannot be properly identified.

Importing peptides: the Personal Importation Scheme has hard limits

Australia's Personal Importation Scheme allows an individual to import certain therapeutic goods that are not on the ARTG, in limited quantities, for their own use or that of an immediate family member — and never for sale or supply to anyone else. But this scheme is not an open door for peptides:

• It generally permits up to a three-month supply at the prescribed dose.
• For a substance in Schedule 4 (which covers most peptides), you must hold a prescription from an Australian-registered medical practitioner for the import to be lawful.
• Products must be clearly and accurately labelled so the goods can be identified — the TGA has flagged that unmarked vials, code-only labels, or missing active-ingredient information will be treated as non-compliant.
• Some substances are prohibited imports outright. Melanotan I and II, for example, are not available through any legal Australian channel and are actively targeted in enforcement.

Where imported peptides do not meet these requirements, the TGA can direct the Australian Border Force to seize and destroy them, and importers have faced infringement notices and fines. See the TGA's Personal Importation Scheme page and its guidance on your responsibilities when importing, compounding and supplying unapproved peptide products.

Legitimate access: SAS and Authorised Prescriber

For peptides that are not registered on the ARTG, there are legitimate, regulated pathways that run through a doctor — not through a website. The Special Access Scheme (SAS) lets a registered health practitioner apply to supply an unapproved therapeutic good to a single patient on a case-by-case basis. The Authorised Prescriber (AP) pathway lets an approved medical practitioner prescribe an unapproved good to a defined class of patients under their care. Both sit under the Therapeutic Goods Act 1989, require AHPRA registration, and carry reporting obligations to the TGA. These pathways — described on the TGA's access to unapproved therapeutic goods for individual patients page — are the lawful route for clinically justified peptide use, not a "research" purchase from an overseas vendor.

Selling or supplying unapproved peptides is illegal

The hardest legal line in Australia sits on the supply side. Importing, advertising, or supplying unapproved therapeutic goods — including unregistered peptides marketed for human use — is an offence under the Therapeutic Goods Act 1989. The TGA pursues these matters with infringement notices, fines, seizures, and prosecution, and individuals have been fined for importing unapproved peptides. Compounding pharmacies operate under their own strict professional and TGA rules and are not a workaround for mass-supplying unapproved peptides. If a website is selling "research peptides" into Australia for human use, that supply is almost certainly unlawful, regardless of how the product is labelled.

The bottom line

Australia treats peptides far more strictly than the US or UK. Approved GLP-1 peptides (semaglutide, tirzepatide) are legal with a prescription; the rest are overwhelmingly Schedule 4 prescription-only or unapproved goods, with some — like the melanotans — effectively prohibited. The Personal Importation Scheme has real limits and excludes much of what people try to import, and the lawful route for unapproved peptides is a doctor using SAS or Authorised Prescriber, not an online "research only" order. For the broader regulatory picture, see our peptide legal status cornerstone and the are peptides legal? guide.

Marko Maal, MSc Pharmacy reviewed this guide for accuracy and framing. Reviewer attribution does not constitute legal advice or a doctor-patient relationship.